Hematologic Neoplasms
Research News and Information

Sunday, November 22, 2009

Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.

29 Nov 2009 BACKGROUND: Beta thalassemia is one of the most common genetic disorders in the world. The aim of this study was to determine the frequency, characteristics, and pattern of malignancies in patients with beta thalassemia major (BTM) and beta ... Read more...

p38 Mitogen-activated protein kinase and hematologic malignancies.

30 Oct 2009 CONTEXT: p38 mitogen-activated protein kinase (MAPK) signaling has been implicated in responses ranging from apoptosis to cell cycle, induction of expression of cytokine genes, and differentiation. This plethora of activators conveys the complexity ... Read more...

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

30 Oct 2009 There are emerging data to suggest a role for genetic factors in the pathogenesis of multiple myeloma (MM). Based on small numbers, certain solid tumors have been reported to occur more frequently among blood relatives of patients with MM. Using ... Read more...

Latest indexed articles for 'Hematologic Neoplasms'

These are the very latest articles for this heading:

• Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran. 29 Nov 2009
• p38 Mitogen-activated protein kinase and hematologic malignancies. 30 Oct 2009
• Pediatric hematology oncology in Brazil. 30 Oct 2009
• Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. 30 Oct 2009
• TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity. 15 Sep 2009
• Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can. 15 Sep 2009
• Venous thromboembolism in the hematologic malignancies. 12 Sep 2009
• Prevention of thrombosis in ambulatory patients with cancer. 12 Sep 2009
• Unintended pregnancy after gonadal failure chemoprevention with gonadotropin-releasing hormone agonist in women with hematologic malignancies. Sep 2009
• [Research progress of zebrafish as a model system for hematological neoplasms] 30 Aug 2009
• Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. 30 Aug 2009
• Natural genetic diversity as a means to uncover stem cell regulatory pathways. 30 Aug 2009
• Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. 30 Aug 2009
• Ocular findings after allogeneic hematopoietic stem cell transplantation. 30 Aug 2009
• Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. 30 Aug 2009
• A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production. 30 Aug 2009
• Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. 30 Aug 2009
• Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. 25 Aug 2009
• Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. 25 Aug 2009
• Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry. 20 Aug 2009

See a longer list of these articles.

Technical information about 'Hematologic Neoplasms'

Definition: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Descriptor UI: D019337

Alternative terms: Hematologic Neoplasms; Malignancies, Hematologic; Malignancy, Hematologic; Hematological Neoplasms; Hematological Neoplasm; Neoplasm, Hematological; Neoplasms, Hematological; Neoplasms, Hematologic; Hematologic Neoplasm; Neoplasm, Hematologic; Hematological Malignancies; Hematological Malignancy; Malignancies, Hematological; Malignancy, Hematological; Hematologic Malignancy; Hematologic Malignancies; Hematopoietic Neoplasms; Hematopoietic Malignancies; Hematopoietic Malignancy; Malignancies, Hematopoietic; Malignancy, Hematopoietic; Neoplasms, Hematopoietic; Hematopoietic Neoplasm; Neoplasm, Hematopoietic;

Related Mesh Headings: Leukemia; Lymphoma;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.448; C15.378.400;

History Note: 97

Technical Notes: GEN or unspecified only; prefer LEUKEMIA or LYMPHOMA or their specifics; do not use /blood supply /second /secret; DF: HEMATOL NEOPL